Items Tagged ‘Forefront’
October 30, 2018
Have You Read the September 2018 Issue of Forefront Magazine?
No? This is your chance! Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in online and email newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research. The September 2018 edition of email/online Forefront features: A message from Mayo Clinic Cancer Center director, Robert Diasio, M.D. Article: Mayo Researchers a Step Closer to DNA Test […]
Tags: cancer, Forefront, Mayo Clinic Cancer Center, research
November 2, 2017
Targeting a Molecular Abnormality
Microsatellite instability (MSI) might sound like something a NASA engineer would study. But it’s actually a molecular abnormality found in 15 percent of colorectal cancers, explains Mayo Clinic medical oncologist and gastroenterologist Frank A. Sinicrope, M.D., who is testing an immunotherapy drug that could help patients with this subtype of colorectal cancer. Just recently, researchers […]
Tags: biomarkers, clinical trials, Forefront, Mayo Clinic Cancer Center
October 26, 2017
New Issue of Forefront Magazine
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in print and online magazine editions annually and in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. View the online edition. View the email newsletter. Subscribe.
October 19, 2017
Cycling Through Multiple Myeloma
It was Labor Day 2009 when Andy received the same diagnosis his wife had heard 12 years earlier — a one in 14 million possibility. Andy’s wife Sue was diagnosed on April 11, 1997, with multiple myeloma, and she died on May 1. She never came out of the hospital. Their kids were 12 and […]
Tags: clinical trials, Forefront, Mayo Clinic Cancer Center, multiple myeloma
July 18, 2017
Check Out the Latest Issue of Forefront Magazine
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in print and online magazine editions annually and in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. View the online edition. View the email newsletter. Subscribe.
June 6, 2017
Meet the researchers – Sandra J. Gendler, Ph.D. & Peter A. Cohen, M.D.: The Dynamic Duo
On the brink of discovery, Sandra J. Gendler, Ph.D., and Peter A. Cohen, M.D., take a moment to reflect on a collaboration and friendship that began in 2008 when Dr. Cohen made the move to Mayo Clinic in Arizona. “I recognized that this chance to work closely with Sandy offered a once-in-a-lifetime opportunity to figure […]
Tags: cancer, clinical trials, Forefront, immunotherapy, Mayo Clinic Cancer Center
May 18, 2017
Meet the researcher – Betty Kim, M.D., Ph.D.: Harnessing Nanotechnology to Study Cancer
When you are a driven neurosurgeon but not a morning person, sometimes it’s about your socks. “I lose no time matching,” says Mayo Clinic’s Betty Kim, M.D., Ph.D. “They’re all the same color, so I can get an extra minute of sleep.” Yet, in her daily work, misplaced colors are critical. Dr. Kim is trained […]
Tags: cancer, Forefront, Mayo Clinic Cancer Center, nanomedicine
May 2, 2017
Meet the researcher – Alex Adjei, M.D., Ph.D.: The Power of Hope
There’s a reason Mayo Clinic oncologist Alex A. Adjei, M.D., Ph.D., spends so much time in the lab testing molecular solutions to cancer — it gives his patients hope. When Dr. Adjei started as a lung cancer specialist about 20 years ago, patients with the disease had a dismal prognosis. There was basically one treatment […]
February 28, 2017
More women eligible for Herceptin, benefit uncertain
Updated guidelines underscore need to identify the most optimal candidates for HER2-directed therapy. Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test positive for HER2 breast cancer, Mayo Clinic researchers have found. The researchers published their HER2 breast cancer study results online July 25, 2016, in […]
February 16, 2017
Drug combo safe for diffuse large B-cell lymphoma
Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy. The drug everolimus can be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma, according to the results of a pilot study by Mayo Clinic researchers. The researchers published their study findings in the July 2016 issue of […]